study News newsbot.ch

»

Mühleberg Nuclear Power Plant ceases operations

Mühleberg Nuclear Power Plant ceases operations

2019-12-20 08:20:59


Europäische Kommission »

Erasmus+: EU will invest over €3 billion in young Europeans to study or train abroad in 2020

2019-11-05 15:25:20


»

Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer

Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer

2019-09-30 19:20:02


»

FDA approves Roche’s Rituxan (rituximab) in children with two rare blood vessel disorders

2019-09-30 07:20:03


»

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

2019-09-28 06:20:30


»

Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma

2019-09-27 14:20:09


ETH-Rat »

25 Professorinnen und Professoren an den beiden ETH ernannt

2019-09-26 16:55:01


»

FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis

2019-09-18 05:20:01


»

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

2019-09-13 13:20:50


»

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer

2019-09-13 13:20:50


»

Roche’s satralizumab significantly reduced relapse risk in second  positive phase III study for neuromyelitis optica spectrum

Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum

2019-09-12 13:20:00


»

Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy

2019-09-12 13:20:00


»

Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS

2019-09-10 05:40:12


»

Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS

2019-09-04 06:40:12


»

Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86%

2019-09-02 22:40:14


»

European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer

2019-08-29 07:40:16


Schweizer Nationalfonds »

Sexualerziehung: Deshalb sollten Schule und Eltern zusammenarbeiten

Sexualerziehung: Deshalb sollten Schule und Eltern zusammenarbeiten

2019-08-28 22:55:04


»

FDA approves Roche’s Rozlytrek (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours

2019-08-16 16:40:40


»

Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer

2019-08-05 05:40:23


»

CHMP recommends EU approval of Roche’s Tecentriq in combination with chemotherapy as an initial treatment of adults with extensive-stage small cell lung cancer

2019-07-26 11:20:11



Suchresultate als RSS-Feed